Samuel Ogunsalu

Director @Axis Medtech

London, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

May 2025 — Present

Director @Axis Medtech

View department →

Axis is a MedTech company seeking to bring to market a variety of technologies that can be transformative to people\'s lives, and capable of scaling on a global basis-Axis builds companies when it can control and drive development from the ground up- When Axis cannot take control, it still deploys capital only when its involvement can be transformative, unlocking clinical, regulatory, or commercial breakthroughs- Investments are milestone-based to ensure efficient use of capital and measurable progress- We maintain a focused yet pragmatic approach to opportunity selection- The portfolio strategy allows value realization through exit flexibility: full portfolio or asset-by-asset- Each opportunity is selected for its potential to solve a real-world healthcare problem on a global scale- Axis investments are always timed to coincide with an inflection point

EDUCATION

N/A

UCL

Master of Science - MSc (Eng)

N/A

Aberystwyth University

Bachelor of Science - BSc

SKILLS

Pharmaceutical IndustryLife SciencesMolecular BiologyDrug DiscoveryR&DClinical TrialsBiotechnologyScienceBiochemistryLicensingCommercializationTechnology TransferOncologyImmunologyLifesciencesCorporate FinanceMedical DevicesBiopharmaceuticals

ABOUT SAMUEL OGUNSALU

Co-Founder, Corporate Strategy, Business & Commercial Development, Licensing, Corporate Finance

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Samuel Ogunsalu — Director at Axis Medtech in London, GB | Unifers